CD2 and leukemia: However, transgenic expression of GATA3, under the control of the CD2 promoter, which drives expression in all lymphocytes, predisposes mice to develop T-ALL-like disease with trisomy of chromosome 15 and activation of NOTCH1, similar to what is seen in E2a-/- leukemias, although with longer latency (47, 119).